ArticleFrontiers in immunology2025

Lactylation prognostic signature identifies DHCR7 as a modulator of chemoresistance and immunotherapy efficacy in bladder cancer.

Yuanqiao Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.